Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study

Table 1 General clinical data of three groups

Group	Cases		Age	Etiological factor				APACHII
	Male:	Female		Biliary	Alcoholemia	Injury	Others
Garlicin	12:	13	51.4 ± 15.2	14	6	1	4	11.8 ± 3.8
Fluconazole	12:	10	48.7 ± 17.3	11	6	-	5	13.2 ± 2.5
Control	13:	10	50.5 ± 20.1	11	7	1	4	11.6 ± 4.7

There were no statistically significant differences in three groups.

Table 2 Incidence rate of fungal infection in 3 groups

Group	Cases	Rate of fungal infection	Times of fungal infection after SAP (d)
Garlicin	25	4 (16%)a	39-57
Fluconazole	22	2 (9%)b	35-62
Control	23	7 (30%)	24-183

^aP < 0.05,

^bP < 0.01 vs control.

Table 3 Treatment results of fungal infection in 3 groups

Group	Rate of fungal clearance	Mortality#	Times of Hospitalization
Garlicin	3 (75%)a	1 (25%)a	48.1 ± 30.7a
Fluconazole	-	2 (100%)	43.3 ± 26.9b
Contrast	4 (57%)	3 (43%)	57.4 ± 27.3

Note: # Mortality is the percentage (%) of patients who died of fungal septicemia.

^aP < 0.05,

^bP < 0.01 vs control.